Adenocarcinoma of Head of Pancreas
5
0
0
3
Key Insights
Highlights
Success Rate
75% trial completion
Treatment Research
7 treatments under study, led by Neoadjuvant Chemotherapy
Research Leaders
10 sponsors active, led by Huashan Hospital
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
20.0%
1 terminated out of 5 trials
75.0%
-11.6% vs benchmark
0%
0 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 3 completed trials
Clinical Trials (5)
Comparison of Two Needles (19G Flex Versus 22G Standard) for Pancreatic Solid Tumors Diagnosis
Trial Evaluating the Efficacy of Laying a Biliary Stent for Producing a Heavy Chemotherapy in Unresectable Pancreatic Adenocarcinomas
Neoadjuvant Folfirinox Followed by Capecitabine and Limited Field Radiation for Localized Pancreatic Head Adenocarcinoma
Pancreatic Head and Peri-ampullary Cancer Laparoscopic vs Open Surgical Treatment Trial (PLOT)
Resectability of Pancreatic Head Cancer by Contrast-enhanced MDCT:a Multi-center Study
Research Network
Common Treatments
- Neoadjuvant Chemotherapy1
- Laparoscopic Surgery1
- Chemoradiation1
- Puncture Of Head Of Pancreas1
- Type Wallflex Or Evolution Biliary Stent System1
Active Sponsors
- Huashan Hospital1
- French Society of Digestive Endoscopy1
- Shanghai Cancer Hospital, China1
- Institut Paoli-Calmettes1
- Meng Su Zeng1
Top Investigators
Radiology Department, Ruijin Hospital Affiliated to Shanghai Jiaotong University, China
Gem Hospital & Research Centre Private Limited, Coimbatore, Tamil Nadu, India
Gem Hospital & Research Centre Private Limited, Coimbatore, Tamil Nadu, India
Radiology Department, Huashan Hospital, Fudan University, China
Radiology Department, Changhai Hospital Affiliated to Second Military Medical University
Related Conditions
- Carcinoma Of Ampulla Of Vater1
- Cholangio Carcinoma1
- Duodenal Adenocarcinoma1